The shares of GlaxoSmithKline ($GSK) cheered on Monday after the British pharmaceutical giant announced that its chief ...

GSK plc has announced its total voting rights and capital as of September 30, 2025. The company’s issued share capital consists of over 4.3 billion ordinary shares, with a total of approximately 4.07 ...

The FDA has reapproved leucovorin, a form of folate, which was previously withdrawn by GlaxoSmithKline. This drug is used in ...

The pharmaceutical and biotechnology company GlaxoSmithKline has fired one of their employees who launched into a homophobic and racist rant whilst on an American Airlines flight. In viral video ...

The market is primed for growth, driven by innovations in stem cell therapies, gene editing, and tissue engineering ...

Indoor dining, workout classes, concerts. These once commonplace events are coming back into daily life. But because of Covid-19, everyone now has a different level of comfort. What happens in the ...

GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. July 14, 2010— -- In the face of mounting evidence that GlaxoSmithKline withheld important safety data on their ...

A partnership between a large British drugmaker and a startup that discovers drugs using artificial intelligence has borne fruit. Oxford, UK-based Exscientia said Wednesday that it had delivered the ...

GlaxoSmithKline (GSK-0.81%) has confirmed plans to separate its consumer and pharmaceutical business units. However, an activist investor appears to want the big drugmaker to take more drastic actions ...

Forbes contributors publish independent expert analyses and insights. #1 stock picker for 39 straight months on SumZero. Data is my edge. This week’s Filing Season Finds report highlights some of the ...